Scientific and medical literature could prove to be a substantial source for valid information in order to monitor the risk-benefit balance and safety profile of medicinal products. When it comes to a data source on instances of suspected adverse drug reactions (these are additionally regularly named as individual case security reports – ICSRs) medical and science literature are indispensable. Since the principle goal of the screening is to recognize ICSR and/or any significantly new data from studies relating to security and adequacy (epidemiological, clinical and non-clinical) literature screening has become a vital aspect of pharmacovigilance.